Cargando…
Benznidazole treatment decreases IL-6 levels in Trypanosoma cruzi-infected human adipocytes differentiated from adipose tissue-derived stem cells
BACKGROUND: Trypanosoma cruzi, which causes Chagas disease (CD), is a versatile haemoparasite that uses several strategies to evade the host’s immune response, including adipose tissue (AT), used as a reservoir of infection. As it is an effective barrier to parasite evasion, the effectiveness of the...
Autores principales: | Moreira, Leyllane Rafael, Silva, Ana Carla, da Costa Oliveira, Cíntia Nascimento, da Silva Júnior, Claudeir Dias, Nascimento, Amanda Vasconcelos, Oliveira, Kamila Kássia dos Santos, Soares, Ana Karine de Araújo, Saraiva, Karina Lidianne Alcântara, de Paiva Cavalcanti, Milena, de Lorena, Virginia Maria Barros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599316/ https://www.ncbi.nlm.nih.gov/pubmed/37878830 http://dx.doi.org/10.1590/0074-02760220295 |
Ejemplares similares
-
Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain
por: Fonseca, Kátia da Silva, et al.
Publicado: (2021) -
Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo
por: Batista, Denise da Gama Jaén, et al.
Publicado: (2011) -
Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease
por: Assíria Fontes Martins, Tassiane, et al.
Publicado: (2015) -
Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations
por: Lima, Davi Alvarenga, et al.
Publicado: (2023) -
A novel ABCG-like transporter of Trypanosoma cruzi is
involved in natural resistance to benznidazole
por: Zingales, Bianca, et al.
Publicado: (2015)